Negative estrogen receptors and positive progesterone receptors breast cancers
Authors:
- 1 February 2021
- journal article
- research article
- Published by Elsevier in Journal of Gynecology Obstetrics and Human Reproduction
- Vol. 50 (2) , 101928
Abstract
No abstract availableKeywords
This publication has 44 references indexed in Scilit:
- Estrogen receptor negative/progesterone receptor positive breast cancer is not a reproducible subtypeBreast Cancer Research, 2013
- Prognostic Significance of Progesterone Receptor–Positive Tumor Cells Within Immunohistochemically Defined Luminal A Breast CancerJournal of Clinical Oncology, 2013
- Progesterone receptor loss identifies Luminal B breast cancer subgroups at higher risk of relapseAnnals of Oncology, 2012
- Survival Benefit of Tamoxifen in Estrogen Receptor-Negative and Progesterone Receptor-Positive Low Grade Breast Cancer PatientsJournal of Breast Cancer, 2012
- Combinatorial biomarker expression in breast cancerBreast Cancer Research and Treatment, 2010
- The Clinicopathologic Characteristics and Clinical Outcomes of Estrogen Receptor Negative and Progesterone Receptor Positive Breast CancerJournal of Breast Cancer, 2010
- Breast cancer patients with estrogen receptor-negative/progesterone receptor-positive tumors: being younger and getting less benefit from adjuvant tamoxifen treatmentJournal of Cancer Research and Clinical Oncology, 2008
- It Is Not Time to Stop Progesterone Receptor Testing in Breast CancerJournal of Clinical Oncology, 2005
- Prognostic and Predictive Factors in Early-Stage Breast CancerThe Oncologist, 2004
- Time to Stop Progesterone Receptor Testing in Breast Cancer ManagementJournal of Clinical Oncology, 2004